Showing results (2181-2190 of 2,380) with videos related to
Sort By:
Pageof 238
Investigational New Drugs|October 27, 2016
Targeting the protein ubiquitination machinery in melanoma by the NEDD8-activating enzyme inhibitor pevonedistat (MLN4924)Kit Man Wong, Lindsey N Micel, Heather M Selby, et al.Neuromodulation : Journal of the International Neuromodulation Society|March 8, 2024
Examining the Duration of Carryover Effect in Patients With Chronic Pain Treated With Spinal Cord Stimulation (EChO Study): An Open, Interventional, Investigator-Initiated, International Multicenter StudyKaare Meier, Cecile C de Vos, Martine Bordeleau, et al.BMC Cancer|November 5, 2020
RX-5902, a novel β-catenin modulator, potentiates the efficacy of immune checkpoint inhibitors in preclinical models of triple-negative breast CancerJohn J Tentler, Julie Lang, Anna Capasso, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 3, 1999
A Phase I and pharmacokinetic study of temozolomide and cisplatin in patients with advanced solid malignanciesC D Britten, E K Rowinsky, S D Baker, et al.Science (New York, N.Y.)|October 19, 1973
The Lunar Laser Ranging Experiment: Accurate ranges have given a large improvement in the lunar orbit and new selenophysical informationP L Bender, D G Currie, S K Poultney, et al.Critical Care Medicine|September 28, 2021
Physiological Assessment of Delirium Severity: The Electroencephalographic Confusion Assessment Method Severity Score (E-CAM-S)Meike van Sleuwen, Haoqi Sun, Christine Eckhardt, et al.Molecular Cancer Therapeutics|October 7, 2010
Identification of predictive markers of response to the MEK1/2 inhibitor selumetinib (AZD6244) in K-ras-mutated colorectal cancerJohn J Tentler, Sujatha Nallapareddy, Aik Choon Tan, et al.BMJ Open|June 20, 2020
Compliance of smokeless tobacco supply chain actors and products with tobacco control laws in Bangladesh, India and Pakistan: protocol for a multicentre sequential mixed-methods studyZohaib Khan, Rumana Huque, Aziz Sheikh, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 14, 2010
Safety, pharmacokinetics, and pharmacodynamics of AMG 102, a fully human hepatocyte growth factor-neutralizing monoclonal antibody, in a first-in-human study of patients with advanced solid tumorsMichael S Gordon, Christopher S Sweeney, David S Mendelson, et al.Cancer Chemotherapy and Pharmacology|June 15, 2024
Population pharmacokinetics of TLD-1, a novel liposomal doxorubicin, in a phase I trialAnna M Mc Laughlin, Dagmar Hess, Robin Michelet, et al.Pageof 238